Development and Preclinical Testing of Nasal Aerosol for the Delivery of Novel Spray Dried Polyherbal Formulation to Treat Alzheimer’s Disease by Nadendla, Rama Rao & Santhi Priya, Nagam
Nadendla et al                                                                                                      Journal of Drug Delivery & Therapeutics. 2020; 10(3):185-194 
ISSN: 2250-1177                                                                                  [185]                                                                                 CODEN (USA): JDDTAO 
Available online on 15.05.2020 at jddtonline.info 
Journal of Drug Delivery and Therapeutics 
Open Access to Pharmaceutical and Medical Research 
© 2011-18, publisher and licensee JDDT, This is an Open Access article which permits 
unrestricted non-commercial use, provided the original work is properly cited 
Open  Access                                                                                                                                            Research Article  
Development and Preclinical Testing of Nasal Aerosol for the Delivery of 
Novel Spray Dried Polyherbal Formulation to Treat Alzheimer’s Disease  
Rama Rao Nadendla*, Nagam Santhi Priya 
Department of Pharmaceutics, Chalapathi Institute of pharmaceutical sciences, Lam, Guntur, Andhra Pradesh, India 
 
ABSTRACT  
Alzheimer’s disease (AD) is an irreversible, progressive brain disorder that slowly destroys memory and thinking skills and eventually the 
ability to carry out the simplest tasks. The present investigation was undertaken to evaluate anti-alzheimer’s activity of novel herbal aerosol 
spray formulation containing pure extracts of Curcuma longa, Commiphora wightii and Withania somnifera.Pressurized aerosol packs containing 
polyherbal spray dried dispersions in the concentration range of 0.5, 1 and 2% w/v dispersed in 10/90, 20/80, 30/70/ 40/60, 5 0/50) 
propellant blends of HFA-134a were developed in 3 in 1 aerosol filling machine and evaluated. Behavioural studies were performed in male 
wistar rats and histopathological studies were performed. The preparations were also assessed for AChE inhibitory activity. Results with P 
values < 0.05 were considered statistically significant. Chitosan exhibited compatibility with the polyherbal extracts in FT-IR studies. DSC 
thermogram revealed an endothermic peak of 65ᵒC with chitosan. Spray dried poly herbal extracts exhibited a spherical morphology particle 
size distribution of 5-50µm with a practical yield of 20-30%. Aerosol formulations exhibited a particle size range below 10µm. average weight 
per actuation of canister was 7-8mg with a total 210 deliveries per pack. Zeta potential of the formulations was ±0.997. HPTLC fingerprinting 
showed band ranges at 256 and 366nm. The optimized aerosol spray in behavioral tests exhibited 10mg/kg and 20mg/kg intranasally reversed 
the scopolamine induced amnesia. Histopathological findings showed decreased Ach activity in male albino wistar rats. Percentage inhibition of 
formulation and standaed on AChE activity shoed an IC50 of 62% for 10mg/kg aerosol spray and 72% with 20mg/kg aerosol spray dosing.  
Keywords: alzhiemer’s disease; herbal; spray dried chitosan; aerosol; nasal spray;  
 
Article Info: Received 19 March 2020;     Review Completed 25 April 2020;     Accepted 05 May 2020;     Available online 15 May 2020 
Cite this article as: 
Nadendla RR, Santhi Priya N, Development and Preclinical Testing of Nasal Aerosol for the Delivery of Novel Spray 
Dried Polyherbal Formulation to Treat Alzheimer’s Disease, Journal of Drug Delivery and Therapeutics. 2020; 
10(3):185-194   http://dx.doi.org/10.22270/jddt.v10i3.4112                                                                                                                    
*Address for Correspondence:   




Alzheimer’s disease is a neurodegenerative disorder of 
uncertain cause and pathogenesis. It mostly affects the 
elderly. [1] In mild cases it results in forgetfulness and as the 
disease progresses it affects both short- and long-term 
memory. It is commonest cause of dementia in elderly, 
responsible for approximately 60-80 % of cases. It has 
significant effect on quality of life. Currently available 
treatments can modulate the disease course and ameliorate 
some symptoms but no proven effective therapeutic cure for 
Alzheimer has been identified to date. Traditional medicinal 
system in India particularly Ayurveda mentions 
neuroprotective actions of plant drugs like Brahmi, 
Shankhapushpi, Amla, Guduchi, 
Tulsi, Ashwagandha and Haritaki, which can help in 
improving the treatment armamentarium for Alzheimer’s 
disease.[2-3] The understanding of Alzheimer’s disease 
neurobiology is improving now and the search for better 
treatment options is still on. This provides an opportunity 
for more research on integrated approach using existing 
therapies, traditional and alternative medicines with newer 
treatments and potential candidates for management of 
Alzheimer’s disease. [9] Based on other existing evidence, it 
was depicted that oxidative stress has a considerably 
important role to play in this process. The hippocampal 
network, which is the main part of the brain has such a 
prominent role in long-term memory and spatial navigation, 
and it is also one of the strikingly first regions of the brain 
that can meticulously show damages, memory problems and 
disorientation in AD patients. Novel drug delivery systems 
has opened new areas for research in herbal drugs. In order 
to improve stability, studies are mostly dedicated to solid 
forms of polymeric systems. An interesting approach is 
spray drying technique. spray drying technique is widely 
used in pharmaceutical field since it allows the preparation 
of dry powders with specific characteristics such as particle 
size and shape. In addition, formulation process including 
encapsulation, complex formation and even polymerization 
can be accomplished in a single step. [8]. Use of natural 
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biopolymers in drug delivery because of their 
biodegradability and biocompatibility is another choice for 
herbal drug encapsulation. Chitosan is a natural cationic 
polysaccharide of the linear co polymers which is suitable 
for medical applications. [7-8] In this study, we pioneered the 
aerosol delivery of a spray dried microparticle formulation 
in a rodent model. The efficiency of different dosing 
techniques and formulations to target the brain were 
performed and compared.  
MATERIALS AND METHODS 
Materials  
Curcumin, guggul and ashwagandha extracts were 
purchased from sun pure extracts (Hyderabad). All other 
chemicals were of analytical grade and procured from 
central stores, chalapathi institute of pharmaceutical 
sciences. 
Development of microparticles by spray drying 
technique: 
Spray-dried (SD) particles at different ratios were obtained 
by spray drying chitosan solutions of curcumin, guggul, 
ashwagandha under the conditions outlined in Table 1. The 
feeding solution was prepared by dissolving each 
component in methanol to make a total concentration of 
0.15% w/v. The feed solution was passed through a stainless 
steel 0.7 mm diameter atomizing nozzle via a peristaltic feed 
pump at a flow rate of 15 mL/minute (pump rate 50%). A set 
inlet temperature of 150°C ± 2°C (primary drying step) 
resulted in outlet temperatures of 60°C ± 3°C. The 
atomization gas flow rate was 600 L/hour, and the 
aspiration rate was 35 m3 /hour (100% aspirator). The 
resultant dry powder was blown through a high-
performance cyclone separator and collected in the sample 
container. All SD powders were stored in glass vials sealed 
with parafilm in glass desiccators in the freezer at -23°C 
under ambient pressure. [20] (TABLE1) (Fig 12) 
Development of pressurized aerosol: 
 Pressurized packs containing chitosan polyherbal 
dispersions in the concentrations of 1% and 2% are 
solubilized in purified water and a fraction of tween 80 
surfactant as stabilizer. These were mixed in 10/90, 20/80, 
30/70, 40/60 and 50/50 propellant blends of HFA-134 
filling and crimping procedures in 3 in 1 aerosol filling 
machine. Gross leakage of the aerosol packs were detected 
immediately after manufacture by immersion in water bath 
at 45ᵒC. the aerosol packs were further characterized for 
qualitative and quantitative tests. (Fig.13) 
Percentage yield: 
The weights of spray dried powders were collected. The 
yield was calculated by dividing these quantities by the total 
mass introduced in the preparation submitted to spray 
drying.  
Scanning electron microscopy for morphology and size 
analysis and zeta potential: 
The SEM pictures spray dried chitosan encapsulating herbal 
formulation by crosslinking were presented in Fig. 1. It can 
be seen that the spray dried chitosan microspheres were 
spherical with wrinkles on their surface. The spray drying 
parameters induced remarkable change in the surface 
morphology. Zeta sizer analysis report was presented in Fig 
2. All the dynamic light scattering studies were performed at 
25.0 ± 0.1 ᵒC at 20 seconds intervals for repeated 
measurements. For the zeta potential measurement, the 1mL 
of diluted microparticle suspension was put in a universal 
folded capillary cell equipped with platinum electrodes. The 
electrophoresis mobility was measured and the zeta 
potential was calculated by the dispersion technology 
software provided in Malvern. (Fig.1, Fig.2 and Fig.3) 
Infra-red spectroscopy 
Infrared (FTIR) spectroscopy Fourier transform infrared 
spectrometry (FTIR) spectra of pure extracts (Sun pure 
extracts), spray dried formulations were recorded with a 
Varian, Inc., 7000e step-scan spectrometer (Agilent 
Technologies, Santa Clara, CA, USA). The spectra were 
collected with no further processing of the samples. The 
powder was placed on the sampling area, covered with a 
glass cover slip, and held in place with a specialized clamp. 
The spectra were scanned at an 8 cm-1 spectral resolution 
from 700 cm1 to 4,000 cm-1. The data were collected and 
analyzed using Varian Resolutions software (Agilent 
Technologies).  
Differential scanning calorimetry (DSC)  
Phase transition of pure extracts (as supplied by the 
manufacturer), SD formulations were studied by 
thermogram obtained using the TA Q200 DSC system (TA 
Instruments, New Castle, DE, USA) equipped with T-Zero® 
technology and an automated computer-controlled RSC-90 
cooling accessory (TA Instruments). Approximately 3 mg of 
powder was carefully weighed into hermetic anodized 
aluminum T-Zero® DSC pans (TA Instruments) and sealed 
with the T-Zero® hermetic sealer (TA Instruments). An 
empty, hermetically sealed, anodized aluminum pan was 
used as reference. DSC measurements were performed at 
the heating rate of 5.00°C/minute from 0°C to 350°C. UHP 
nitrogen gas (Scott-Gross Company, Inc.,) was used as the 
purging gas at a purge rate of 50 mL/minute. The glass 
transition temperature (Tg) was calculated using TA 
Universal Analysis (TA Instruments). (Fig.4 and Fig.5) 
Qualitative analysis of spray dried formulations: 
HPTLC analysis was carried out by taking 10 mg of spray 
dried formulations. It was dissolved in 1 ml methanol and 
centrifuged at 3000 rpm for 5 minutes and used for HPTLC 
analysis as test sample. The aliquot of 2 μl of the samples 
were loaded as 6 mm band length at a 15.0 mm application 
position in a 10 × 10 cm silica gel 60 F 254 TLC plate using a 
CAMAG automatic TLC sampler IV (CAMAG, Switzerland). 
Distance between the tracks was maintained at 23.3 mm. 
The plates were prewashed with chloroform and dried in an 
oven at 60°C for 5 minutes. The samples loaded plates were 
kept in TLC Twin Trough Chamber (20x10cm) for saturation 
with the solvent vapours with respective mobile phase. The 
plates were developed in a linear ascending mode upto 84.9 
mm. (TABLE 2] (Fig.14) 
The mobile phase used is methanol. After the chromoplate 
development time of 20 min, the plate was air-dried for 15 
min to evaporate solvents. These plates were kept in 
photodocumentation chamber (CAMAG Automatic sampler 
4) observed under white light, UV at 254 and 366 nm and 
the images were documented. Separated bands were 
observed in the remission–absorption mode at 254 and 366 
nm operated by winCATS planar chromatography software 
manager. The plate size of 10.0 x 10.0 cm at a sample 
application position between 15.0 mm to 84.9 mm with 
application volume of 2.0 μl to 8.0 μl was maintained to 
record the resolved bands. Derivitization of the plate was 
performed for clear resolution of bands. The plate was fixed 
and scanning was done at 366 nm by TLC Scanner 3 for the 
samples at full resolution.  
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HPTLC profile of the spray dried samples was studied by 
using solvent system methanol, detected under UV 366, 254 
nm and white light. The corresponding HPTLC images are 
presented in the results. 
Qualitative Evaluations of Aerosol Formulations 
Particle size distribution: Binocular Labomed vision 2000 
TM microscope was used for particle size determination. 
Aerosol formulations under evaluation were sprayed on a 
glass slide. The slide was rinsed with CCl4 to prevent the 
excipients particles from interfering with the measurement 
of polyherbal drug particles. After sufficient rinsing with 
CCl4, the slide was placed under the microscope and 
particles were measured by using 100X magnification with 
oil immersion method. At least 100 particles in 25 different 
fields were measured. Results were reported as numbers of 
particles are less than or equal to 5 μm and not more than 10 
μm.  
Leakage rate test: Aerosol containers were weighed and 
inserted in water bath, maintained at 50ºC. After 
equilibration, containers were checked for presence of leaks 
in the form of air bubbles arising from orifice or valve crimp. 
These containers were wiped clean with a tissue paper and 
their weights were recorded (W1). The containers were kept 
in upright position for 3 days and were weighed at the end of 
third day (W2).  
Leakage rate was calculated as: 
Leakage rate: 365*24/ T (W1-W2), Where T= Time in hrs. 
Quantitative Evaluations of Aerosol Formulations 
Average weight per actuation: Canisters were first 
detached from the adaptor body and their weights were 
determined. The first five sprays were fired in air and were 
referred to as “Test Firing”. After the test fire, the canisters 
were thoroughly wiped with a tissue paper and their 
weights were recorded (W1). Five successive deliveries were 
sprayed from the inhaler after placing the canisters back in 
their actuators. The canisters were subsequently removed 
from the adaptor and the valve stem and orifice were wiped 
clean. The containers were weighed again and their weights 
were recorded (W2). (TABLE  8) 
Average weight per actuation = (W1-W2)/5 
Evaluation of Anti-Alzheimer’s activity: 
Experimental Animals:  
SD rats of either sex (200-300g) were maintained for 7 days 
in the animal house of Chalapathi Institute of Pharmaceutical 
Sciences, Guntur under standard conditions temperature (24 
± 10˚ C), relative humidity (45-55%) and 12:12 light: dark 
cycle. The animals were fed with standard rat pellet and 
water ad libitum. The animals were allowed to acclimatize to 
laboratory conditions 48 h before the start of the 
experiment. 6 rats/group were used in all sets of 
experiments. 
Ethical Approval:  
All the protocols were approved by Institutional Animal 
Ethical Committee (IAEC) and conducted according to 
Committee for the Purpose of Control and Supervision of 
Experimental Animals (CPCSEA) registered no: 
17/IAEC/CLPT/2018-2019 at Department of Pharmacology, 
Chalapathi Institute of Pharmaceutical Sciences, Guntur.   
Selection of Dose and Treatment Period:   
The learning and memory enhancing activity of the spray 
dried formulation was investigated using scopolamine-
induced amnesia at a dose of 0.5mg/ml in intra peritoneal 
route. The test animals were randomly chosen and divided 
into five groups having 6 rats in each as follows:   
Group I:  Normal control  
Group II: (Inducing Group) scopolamine  0.5mg/kg was 
administered i.p for 15 days).  
Group III: (Standard Group) donepezil hydrochloride  (2.5 
mg/kg was administered orally for 15days)  
Group IV: Formulation in low dose (10mg/Kg) was 
administered through nasal route 
Group V: Formulation in high dose (20mg/Kg) was 
administered through nasal route 
Diazepam 1mg/kg was administered to rats and TL was 
noted after 45 min of injection on 8th day and after 24hrs. 
Extracts and standard Donepezil hydrochloride were 
administered for successive 8 days. After 60 min of 
administration of the last dose on 8th day, Diazepam 
1mg/kg i.p was administered. 
Investigation of learning and memory activity in 
Alzheimer’s model by using 8-arm radial maze (8-arm) 
(Fig.7,8 and 10) 
Behavioral Study:   
 Before starting the behavioral studies 1 week training was 
conducted. Only food and water was administered during 
this period.  
8 arm Radial Maze:  
 The radial arm maze (RAM) has become an essential tool for 
testing memory in rats. The spatial memory was evaluated 
by the instrument. Open type radial arm maze was used in 
the study. It had a circular central arena and 8 equally sized 
arms (20 x 60 cm). Small dishes with animal food was kept 
at far end inside each arm was mounted. Initially animals 
were habituated to the environment. (35) In the present 
study, baited and unbaited arms were fixed throughout the 
tests. The 1st, 3rd , 5th , and 7th  arms were baited while the 
2nd , 4th , 6th , and 8th  arms were unbaited. The rats was 
placed in the centre of the maze and allowed to freely 
explore the maze for 10 minutes on the first day. The rats 
were required to take the food pellets from each arm 
without making a re-entry into the arm already visited. The 
trail was terminated when the animal takes the food reward 
from all the eight arms or after 10 minutes if all the eight 
arms were not visited. Correct score was give when the visits 
an arm and collects the food reward and a maximum score of 
‘8’ can be attained per trail. The first entry into the baited 
arm was recorded as a correct choice. An entry into an 
unbaited arm was considered a reference memory error 
(RME). When a rat re-enters an already visited arm it was 
taken as a working memory error (WME).  
Labrynth maze: This is a simple way to evaluate behavior in 
rodents such as learning ability, memory, and anxiety. The 
duration of time required for the animal to move from the 
starting point to the stopping point (Arrival Time) is 
recorded. If the animal takes significantly longer to arrive at 
the stopping point, this delay might be explained by external 
factors that lead to decreased cognition. The arrival time is 
determined by when the rat reaches the stop point and then 
stays there for at least 10 sec. (Fig 6 and 9) 
Preparation of Intra nasal spray dried formulation: 
To100mg of spray dried formulation 2 ml of tween80 was 
added and dissolved. To this distilled water is added and 
make up the volume to 100ml (2% tween80) and fill this 
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mixture in to inhalation container and operate the actuator 
for 2seconds. 
Histopathological Studies:  
 At the end of the study the rats were sacrificed on 22nd day 
by using the method decapitation and whole brain was 
collected. Routinely, brain tissue is fixed in 10% formalin. 
The organs are isolated and samples were sent to Embiosis 
labs for interpretion of histopathological studies.  
Tissue preparation: 
Rats were deeply anesthetized with 3.5 % chloral hydrate 
(35 mg/100 g, i.p.), and perfused by intracardiac infusion 
with phosphate buffer solution (0.1 M, pH 7.4) followed by 
200 ml of 4 % paraformaldehyde fixative in phosphate 
buffer solution (0.1 M, pH 7.4) for 15 min. Next, their brains 
were removed, isolated, postfixed in 4 % paraformaldehyde 
(24 h), and embedded in paraffin., the whole brain dissected 
out, blotted dry and immediately weighed and rinsed with 
ice-cold isotonic saline. Brain samples were then 
homogenized with 10 times (w/v) ice cold 0.1 M phosphate 
buffer (pH 7.4). Coronal sections (10 μm in thickness) were 
taken from the dorsal hippocampus and stained with 
haematoxylin and eosin. Finally, the numbers of intact 
neurons, in which one can vividly consider a distinctive 
nucleus, in the hippocampal C A1 pyramidal layer were 
counted using a light microscope (BX40, Olympus, New York, 
USA) connected to a camera (Olympus, DP12), and 
quantitatively analysed by Image J software.  
Estimation of In Vitro inhibition of Acetyl Cholinesterase 
Activity: 
Brain tissues were homogenized in 4 volumes of ice-cold 
Tris-HCl buffer (50 mmol/l, pH 7.4) Using a glass teflon 
homogenizer after cutting of brains into small pieces with a 
scissors (for 2 min at 5000 rpm). The homogenate was then 
centrifuged at 5000 rpm for 6 mins to remove debris. Clear 
upper supernatant fluid was taken for estimation. Ellman’s 
reagent, 5, 5’‐dithio‐bis‐(2‐nitrobenzoic acid), also known as 
DTNB, is a versatile water‐soluble compound for 
quantitating free sulfhydryl groups in solution. DTNB reacts 
with a free sulfhydryl group to yield a mixed disulphide and 
2‐nitro‐5thiobenzoic acid (NTB), a measurable yellow‐
colored product with molar extinction coefficient of 14.15 
mM‐1 cm‐1at 412 nm. DTNB is very useful as a sulfhydryl 
assay reagent because of its specificity for ‐SH groups at 
neutral pH, high molar extinction coefficient and short 
reaction time. The enzyme inhibition (%) was calculated 
from the rate of absorbance change with time (V= Abs/Δt) 
the calculation as follows.  
Inhibition (%) = 100 - Change of sample absorbance / 
Change of blank absorbance * 100 
 The experiment was done in triplicate and concentrations of 
the test extract that inhibit the hydrolysis of the substrate 
(acetylcholine) by 50% (IC50) were determined by linear 
regression analysis between the inhibition percentage 
versus the extract concentration. (Fig.15) 
Statistical Analysis: 
 The values are expressed as mean± SEM. The statistical 
analysis was performed using one way analysis of variance 
(ANOVA) followed by Dunnett’s multiple comparison test. 
Comparisons were made between haloperidol group and 
test/standard groups. P values <0.05 was considered 
statistically significant. The statistical analysis was done by 
using Graph pad prism version no: 6.0. (Fig 11) 
 
RESULTS AND DISCUSSION 
In the present research study, an attempt was made to use 
the spray dried herbal aerosol formulation in the treatment 
of alzheimer’s disease. Spray drying of three herbal extracts 
dispersed in chitosan solution was performed. Differential 
scanning colorimetry studies showed good compatibility and 
stability of the herbal extracts with an endothermic peak of 
65ᵒC with chitosan during spray drying. HPTLC 
fingerprinting for qualitative analysis using CAMAG 
automatic TLC sampler 4 revealed a total of three bands in 
all tracks proving the presence of the herbal composition of 
Curcumin, Guggul and Ashawagandha in the spray dried 
formulations under UV 366, 254 nm and white light. 
Morphological parameters showed a particle size 
distribution between 5-45 µm and compatibility was 
assured from FT-IR. Spectra. The herbal compositions which 
are biocompatible were selected to play an important role in 
the long-term treatment of Alzheimer’s disease with fewer 
side effects. Aerosol through nose to brain targeting will be a 
novel outlook in drug delivery and the scope of research can 
be extended. So in our current study the aerosol filling and 
sealing of spray dried dispersions was conducted n 3 in 1 
aerosol filling and sealing machine. The aerosolization 
capacities were assessed in qualitative and quantitative 
tests. Average actuation revealed the total number of 
deliveries to empty the canister, leakage test revealed there 
is no loss of components. HFA 134a as propellant showed 
improved aerosolization of spray dried dispersions with 
improved particle size distribution. Blood brain barrier 
distribution and passage will be benefitted from dispersant 
tween 20. Behavioral studies were conducted. It was 
revealed that Scopolamine produces memory loss in brain 
cell of rats by increasing the GABAergic inhibitory 
facilitation and or by causing oxidative stress by releasing 
free radicals in the brain cavity. The damage by free radicals 
to brain tissue is associated with neurodegenerative 
disorders. The behavioral study results showed that no 
statistically significant differences were observed in brain 
AChE activity of formulation treated rats and control group 
rats. Ach is the most important neurotransmitter involved in 
the regulation of cognitive function. Scopolamine, a 
muscarinic antagonist readily crosses blood-brain barrier 
and blocks AChe receptors at synapse which impair memory 
and acquisition. On the other hand, administration of 
Haloperidol (1.4 mg kg−1, I.P.) significantly increased the 
brain AChE activity, which was reversed (P < .05) by 
formulation administered intra nasally for 21 days. 
Donepezil (0.1 mg kg−1; i.p.) used as a standard drug, 
showed decrease in brain Ach activity of rats. It can also be 
explored from histopathological findings that brain organ 
weights  
were increased in the formulations with low dose as well as 
high dose administration of the developed spray dried 
formulation. The spray dried formulation at a dose of 
10mg/kg and 20mg/kg intra nasally reversed the 
scopolamine-induced amnesia in rats and produced memory 
enhancing activity. This was evident that by penetration of 
spray dried herbal formulations through nasal septum into 
the brain of rats and increase of herbal composition uptake 
through brain.  
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Table 1 Optimized polyherbal microparticles prepared by spray drying technique 
Qualitative tests on aerosol formulations 
Formulations Particle size distribution Leak test 
F-1 100 % particles are below 10µ 0.01% 
F-2 100% particles are below 10µ 0.07% 
F-3 100% particles are below 10µ 0.40% 
 
Table 2 Qualitative tests of aerosol formulations 
Parameters Observations 
Appearance Spherical 
Particle size 5-50 µm 
% yield 20-30% 
 
Table 3: % inhibition of standard and Test formulations on AChE activity 
 
Table 4: Average weight per actuation of pressurized pack 
Formulation Average weight per actuation Number of deliveries 
Spray dried aerosol F-1 7.5 to 8 mg 210 
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Fig.2 Size distribution analysis F-1 
 
Fig.3 Zeta potential of aerosol formulation F-1 
 
Fig.4 DSC report of spray dried Chitosan 
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Fig.5 DSC Report of aerosol formulation F1 
 
 
Fig.6 Comparision of behavioral study results in Labrynth maze 
 
 
Fig.7 comparison of behavioral study results in 8 RAM maze 
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Fig.11 P -value in graph pad prism6 software 
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Fig.12 spray drying of herbal extracts 
 
Fig.13 Aerosol filling in 3 in 1 aerosol filling and sealing machine 
 
Fig.14 HPTLC chromatograms at 254 and 366 nm 
 
 
Fig.15 Percentage Inhibition of Standard and Test formulation on AChE Enzyme Activity 
 
 
 
